Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for corticosteroid-induced memory impairment
NCT01656187Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Memory impairment, sponsored by UT Southwestern Medical Center. Started Jan 2012; status: completed.
02
Drugs
memantine
03
Conditions
Memory impairment
Beyond the preview
Go deeper on NCT01656187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656187.